Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
MDLZ
|
Laura Stein
EVP, CLA and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 8,128 Reduced 31.99% |
$525,475
$64.65 p/Share
|
Feb 24
2022 |
|
MDLZ
|
Laura Stein
EVP, CLA and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct | 21,024 Added 45.28% |
-
|
Feb 24
2022 |
|
MDLZ
|
Glen Walter
EVP & President, North America |
SELL
Payment of exercise price or tax liability
|
Direct | 22,181 Reduced 19.74% |
$1,434,002
$64.65 p/Share
|
Feb 24
2022 |
|
MDLZ
|
Glen Walter
EVP & President, North America |
BUY
Grant, award, or other acquisition
|
Direct | 52,816 Added 31.98% |
-
|
Feb 24
2022 |
|
MDLZ
|
Luca Zaramella
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 22,757 Reduced 12.36% |
$1,471,240
$64.65 p/Share
|
Feb 24
2022 |
|
MDLZ
|
Luca Zaramella
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 56,592 Added 23.51% |
-
|
Feb 24
2022 |
|
CNNE
|
Richard N Massey
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 1.56% |
$122,850
$24.57 p/Share
|
Feb 24
2022 |
|
NSIT
|
Value Act Holdings, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 17,200 Added 0.49% |
$1,707,788
$99.29 p/Share
|
Feb 24
2022 |
|
RSVR
|
Essex Equity Joint Investment Vehicle, LLC |
BUY
Open market or private purchase
|
Direct | 12,945 Added 7.98% |
$89,579
$6.92 p/Share
|
Feb 24
2022 |
|
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100,000 Added 0.21% |
$80,000
$0.8 p/Share
|
Feb 24
2022 |
|
WHG
|
Brian O Casey
CEO |
BUY
Grant, award, or other acquisition
|
Direct | 18,657 Added 4.59% |
-
|
Feb 24
2022 |
|
RWAY
|
Ocm Growth Holdings LLC |
BUY
Open market or private purchase
|
Direct | 16,268 Added 0.08% |
$210,833
$12.96 p/Share
|
Feb 24
2022 |
|
CWAN
|
Durable Capital Partners LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 200 Added 0.0% |
$3,440
$17.2 p/Share
|
Feb 24
2022 |
|
CB
|
Evan G Greenberg
Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 96,375 Added 11.06% |
-
|
Feb 24
2022 |
|
CB
|
Timothy Alan Boroughs
Executive Vice President* |
BUY
Grant, award, or other acquisition
|
Direct | 12,894 Added 16.21% |
-
|
Feb 24
2022 |
|
CB
|
Peter C. Enns
Executive Vice President and* |
BUY
Grant, award, or other acquisition
|
Direct | 13,453 Added 25.36% |
-
|
Feb 24
2022 |
|
CB
|
Annmarie T Hagan
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,885 Added 14.03% |
-
|
Feb 24
2022 |
|
CB
|
John W Keogh
President & COO |
BUY
Grant, award, or other acquisition
|
Direct | 43,524 Added 13.51% |
-
|
Feb 24
2022 |
|
CB
|
Paul J Krump
Vice Chairman, Chubb Group* |
BUY
Grant, award, or other acquisition
|
Direct | 17,378 Added 15.55% |
-
|
Feb 24
2022 |
|
CB
|
John J Lupica
Vice Chrm, Chubb Group* |
BUY
Grant, award, or other acquisition
|
Direct | 31,089 Added 15.25% |
-
|
Feb 24
2022 |
|
CB
|
Juan Luis Ortega
Executive Vice President* |
BUY
Grant, award, or other acquisition
|
Direct | 11,773 Added 21.41% |
-
|
Feb 24
2022 |
|
CB
|
Sean Ringsted
EVP, Chief Risk Officer and* |
BUY
Grant, award, or other acquisition
|
Direct | 11,773 Added 5.24% |
-
|
Feb 24
2022 |
|
CB
|
Joseph F Wayland
Executive Vice President and* |
BUY
Grant, award, or other acquisition
|
Direct | 13,453 Added 13.42% |
-
|
Feb 24
2022 |
|
CINF
|
Michael J Sewell
CFO, EVP & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,435 Reduced 4.97% |
$524,394
$118.24 p/Share
|
Feb 24
2022 |
|
CINF
|
Michael J Sewell
CFO, EVP & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct | 8,016 Added 8.24% |
$358,315
$44.7 p/Share
|
Feb 24
2022 |
|
WTBA
|
Bradley P Peters
Executive Vice President |
BUY
Open market or private purchase
|
Direct | 4,000 Added 11.32% |
$113,800
$28.45 p/Share
|
Feb 24
2022 |
|
PFIS
|
Craig W Best
CEO |
BUY
Grant, award, or other acquisition
|
Direct | 3,566 Added 20.5% |
-
|
Feb 24
2022 |
|
PFIS
|
John R Anderson Iii
EVP/CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 431 Reduced 16.05% |
$20,628
$47.86 p/Share
|
Feb 24
2022 |
|
PFIS
|
John R Anderson Iii
EVP/CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 1,100 Added 29.05% |
-
|
Feb 24
2022 |
|
PFIS
|
Timothy Kirtley
EVP/CHIEF RISK OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 187 Reduced 6.7% |
$8,950
$47.86 p/Share
|
Feb 24
2022 |
|
PFIS
|
Timothy Kirtley
EVP/CHIEF RISK OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 1,248 Added 30.89% |
-
|
Feb 24
2022 |
|
PFIS
|
Neal D Koplin
SR EVP/CHIEF BANKING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 533 Reduced 9.24% |
$25,509
$47.86 p/Share
|
Feb 24
2022 |
|
PFIS
|
Neal D Koplin
SR EVP/CHIEF BANKING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 1,448 Added 20.06% |
-
|
Feb 24
2022 |
|
PFIS
|
Thomas P Tulaney
PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct | 480 Reduced 2.9% |
$22,973
$47.86 p/Share
|
Feb 24
2022 |
|
PFIS
|
Thomas P Tulaney
PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 1,680 Added 9.21% |
-
|
Feb 24
2022 |
|
AMT
|
Thomas A Bartlett |
BUY
Grant, award, or other acquisition
|
Direct | 17,395 Added 7.58% |
-
|
Feb 24
2022 |
|
AMT
|
Olivier Puech
EVP & President, International |
BUY
Grant, award, or other acquisition
|
Direct | 10,254 Added 26.42% |
-
|
Feb 24
2022 |
|
AMT
|
Steven O Vondran
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 10,254 Added 26.51% |
-
|
Feb 24
2022 |
|
AMT
|
Edmund Di Santo |
BUY
Grant, award, or other acquisition
|
Direct | 16,478 Added 9.43% |
-
|
Feb 24
2022 |
|
BMY
|
Giovanni Caforio
Executive Chair of the Board |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 6.21% |
$2,010,000
$67.0 p/Share
|
Feb 24
2022 |
|
DHR
|
Christopher Bouda
VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 921 Added 13.51% |
-
|
Feb 24
2022 |
|
DHR
|
Jose Carlos Gutierrez Ramos
SVP, Chief Science Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,210 Added 32.96% |
-
|
Feb 24
2022 |
|
DHR
|
Jose Carlos Gutierrez Ramos
SVP, Chief Science Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 260 Reduced 10.22% |
$70,606
$271.56 p/Share
|
Feb 24
2022 |
|
MRK
|
Robert M Davis
Chairman, CEO & President |
BUY
Grant, award, or other acquisition
|
Direct | 29,896 Added 10.77% |
$2,197,655
$73.51 p/Share
|
Feb 24
2022 |
|
MRK
|
Sanat Chattopadhyay
Exe V-P & Pres. MMD |
BUY
Grant, award, or other acquisition
|
Direct | 19,836 Added 14.93% |
$1,458,144
$73.51 p/Share
|
Feb 24
2022 |
|
MRK
|
Richard R. De Luca
EVP&Pres, Merck Animal Heallth |
BUY
Grant, award, or other acquisition
|
Direct | 15,966 Added 10.65% |
$1,173,661
$73.51 p/Share
|
Feb 24
2022 |
|
MRK
|
Kenneth C Frazier
Executive Chair |
BUY
Grant, award, or other acquisition
|
Direct | 119,488 Added 14.47% |
$8,783,563
$73.51 p/Share
|
Feb 24
2022 |
|
MRK
|
Julie L. Gerberding
EVP, Chief Patient Officer |
BUY
Grant, award, or other acquisition
|
Direct | 9,550 Added 16.39% |
$702,021
$73.51 p/Share
|
Feb 24
2022 |
|
MRK
|
Rita A Karachun
Sr. VP Fince-Global Controller |
BUY
Grant, award, or other acquisition
|
Direct | 3,478 Added 8.13% |
$255,668
$73.51 p/Share
|
Feb 24
2022 |
|
MRK
|
Michael A Klobuchar
EVP - Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,994 Added 17.56% |
$220,089
$73.51 p/Share
|
Feb 24
2022 |